Huang J, Li X, Zhu Q, Wang M, Xie Z, Zhao T
Front Immunol. 2024; 15():1425847.
PMID: 39086480
PMC: 11288813.
DOI: 10.3389/fimmu.2024.1425847.
Nilsson M, Kozyrev S, Saellstrom S, Johansson S, Andersson G, Lindblad-Toh K
Sci Rep. 2024; 14(1):11624.
PMID: 38773194
PMC: 11109178.
DOI: 10.1038/s41598-024-62265-y.
Patel P, Marinock J, Ajmeri A, Brent L
Int J Mol Sci. 2024; 25(8).
PMID: 38674039
PMC: 11050089.
DOI: 10.3390/ijms25084453.
Wu L, Kalble F, Lorenz H, Zeier M, Schaier M, Steinborn A
Clin Exp Med. 2024; 24(1):47.
PMID: 38427068
PMC: 10907489.
DOI: 10.1007/s10238-024-01307-1.
Richter P, Macovei L, Mihai I, Cardoneanu A, Burlui M, Rezus E
Int J Mol Sci. 2023; 24(19).
PMID: 37833861
PMC: 10572174.
DOI: 10.3390/ijms241914413.
T cells in health and disease.
Sun L, Su Y, Jiao A, Wang X, Zhang B
Signal Transduct Target Ther. 2023; 8(1):235.
PMID: 37332039
PMC: 10277291.
DOI: 10.1038/s41392-023-01471-y.
The star target in SLE: IL-17.
Yang Y, Yan C, Yu L, Zhang X, Shang J, Fan J
Inflamm Res. 2022; 72(2):313-328.
PMID: 36538077
DOI: 10.1007/s00011-022-01674-z.
Safety and efficacy of fecal microbiota transplantation for autoimmune diseases and autoinflammatory diseases: A systematic review and meta-analysis.
Zeng L, Deng Y, Yang K, Chen J, He Q, Chen H
Front Immunol. 2022; 13:944387.
PMID: 36248877
PMC: 9562921.
DOI: 10.3389/fimmu.2022.944387.
Current Evidence for IL-17/23 Blockade for the Treatment of Lupus Nephritis.
Santacruz J, Pulido S, Arzuaga A, Mantilla M, Santos A, Londono J
Cureus. 2022; 13(12):e20087.
PMID: 34993035
PMC: 8720001.
DOI: 10.7759/cureus.20087.
The Microbiota in Systemic Lupus Erythematosus: An Update on the Potential Function of Probiotics.
Guo X, Yang X, Li Q, Shen X, Zhong H, Yang Y
Front Pharmacol. 2021; 12:759095.
PMID: 34887760
PMC: 8650621.
DOI: 10.3389/fphar.2021.759095.
Elevated levels of serum IL-36α in patients with systemic lupus erythematosus.
Wang X, Xiao J, Wang D
Biomed Rep. 2021; 15(3):76.
PMID: 34405048
PMC: 8330003.
DOI: 10.3892/br.2021.1452.
Circulating IL-17 Level Is Positively Associated with Disease Activity in Patients with Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis.
Yin R, Xu R, Ding L, Sui W, Niu M, Wang M
Biomed Res Int. 2021; 2021:9952463.
PMID: 34337065
PMC: 8318742.
DOI: 10.1155/2021/9952463.
Calcineurin and Systemic Lupus Erythematosus: The Rationale for Using Calcineurin Inhibitors in the Treatment of Lupus Nephritis.
Rafael-Vidal C, Altabas I, Perez N, Mourino Rodriguez C, Pego-Reigosa J, Garcia S
Int J Mol Sci. 2021; 22(3).
PMID: 33514066
PMC: 7865978.
DOI: 10.3390/ijms22031263.
Blocking IL-17: A Promising Strategy in the Treatment of Systemic Rheumatic Diseases.
Rafael-Vidal C, Perez N, Altabas I, Garcia S, Pego-Reigosa J
Int J Mol Sci. 2020; 21(19).
PMID: 32993066
PMC: 7582977.
DOI: 10.3390/ijms21197100.
Protective Effects of Probiotic Consumption in Cardiovascular Disease in Systemic Lupus Erythematosus.
de la Visitacion N, Robles-Vera I, Toral M, Duarte J
Nutrients. 2019; 11(11).
PMID: 31694260
PMC: 6893408.
DOI: 10.3390/nu11112676.
Activation of stem cell up-regulation/mobilization: a cardiovascular risk in both mice and humans with implications for liver disease, psoriasis and SLE.
Gemery J, Forauer A, Hoffer E
Vasc Health Risk Manag. 2019; 15:309-316.
PMID: 31692533
PMC: 6716581.
DOI: 10.2147/VHRM.S207161.
Adaptive and Innate Immunity in Psoriasis and Other Inflammatory Disorders.
Schon M
Front Immunol. 2019; 10:1764.
PMID: 31402919
PMC: 6676248.
DOI: 10.3389/fimmu.2019.01764.
Th17/Treg Ratio and Disease Activity in Systemic Lupus Erythematosus.
Yuliasih Y, Rahmawati L, Putri R
Caspian J Intern Med. 2019; 10(1):65-72.
PMID: 30858943
PMC: 6386323.
DOI: 10.22088/cjim.10.1.65.
Lack of IL-17 Receptor A signaling aggravates lymphoproliferation in C57BL/6 lpr mice.
Corneth O, Schaper F, Luk F, Asmawidjaja P, Mus A, Horst G
Sci Rep. 2019; 9(1):4032.
PMID: 30858513
PMC: 6412096.
DOI: 10.1038/s41598-019-39483-w.
Induction therapy downregulates the expression of Th17/Tfh cytokines in patients with active lupus nephritis.
Wang N, Gao C, Cui S, Qin Y, Zhang C, Yi P
Am J Clin Exp Immunol. 2018; 7(4):67-75.
PMID: 30245920
PMC: 6146154.